Top Story

Delayed 2nd Pfizer/BioNTech shot boosts antibodies in elderly; COVID-19 obesity risk higher for men

By Nancy Lapid

(Reuters) – The following is a roundup of some of the latest scientific studies on the novel (More…)

Italy lifts COVID quarantine for EU, UK and Israel from Sunday

ROME (Reuters) -Italy will scrap mandatory quarantine from Sunday for visitors from the European Union, Britain and Israel who test (More…)

Mainland China reports first local COVID-19 cases in more than 3 weeks

SHANGHAI (Reuters) -Mainland China reported 12 new COVID-19 cases on Friday, including its first local transmissions in more than three (More…)

India ‘on war footing’ as coronavirus infections pass 24 million

By Tanvi Mehta and Shilpa Jamkhandikar

NEW DELHI (Reuters) -Prime Minister Narendra Modi sounded the alarm over the rapid spread (More…)

WHO urges rich countries to donate shots instead of vaccinating children

GENEVA (Reuters) – The World Health Organization urged rich countries on Friday to reconsider plans to vaccinate children and instead (More…)

‘U.S. Welcome Patrol’: how some border agents are struggling with Biden’s policy shift

By Ted Hesson, Kristina Cooke and Mica Rosenberg

WASHINGTON (Reuters) – Some U.S. border patrol agents are so frustrated with (More…)

Israel pounds Gaza to curb Palestinian militants but rockets still fly

By Nidal al-Mughrabi and Stephen Farrell

GAZA/JERUSALEM (Reuters) – Israel pummeled Gaza with artillery fire and air strikes on Friday (More…)

ICC prosecutor warns against crimes in escalating Israel-Palestinian violence

By Anthony Deutsch and Stephanie van den Berg

THE HAGUE, Netherlands (Reuters) – Individuals involved in a new eruption of (More…)

Exclusive-India’s most populous state to spend up to $1.36 billion on COVID shots amid shortage

By Krishna N. Das

NEW DELHI (Reuters) -India’s most populous state will spend up to $1.36 billion to buy COVID-19 (More…)

Explainer-Who decides if the world needs COVID-19 booster shots?

By Julie Steenhuysen and Kate Kelland

(Reuters) – Vaccine makers Moderna Inc and Pfizer Inc, with its German partner BioNTech, (More…)